Literature DB >> 31209147

Disparities in Mortality from Noncancer Causes among Adolescents and Young Adults with Cancer.

Chelsea Anderson1, Jennifer L Lund2, Mark A Weaver3, William A Wood4, Andrew F Olshan2, Hazel B Nichols2.   

Abstract

BACKGROUND: Few studies have examined noncancer outcomes among patients diagnosed with cancer as adolescents and young adults (AYA). We examined risk of mortality from noncancer causes after an AYA cancer diagnosis and investigated disparities according to race/ethnicity and other characteristics.
METHODS: Patients with a first primary cancer at ages 15 to 39 years diagnosed during 1987 to 2015 were identified in the Surveillance, Epidemiology, and End Results database (N = 242,940 women, 158,347 men). Survival months were accrued from diagnosis until death or December 2015. Multivariable-adjusted HRs were used to examine disparities in mortality from all noncancer causes, cardiovascular diseases (CVD), and infectious diseases (ID) according to race/ethnicity, geographic region, and county-level characteristics.
RESULTS: For all cancer types combined, the 10-year cumulative incidence of noncancer-related death after AYA cancer was 2% and 5% among women and men, respectively. With adjustment for cancer type, all noncancer mortality was increased among non-Hispanic Black AYAs [HR vs. non-Hispanic White: HRWomen = 2.31; 95% confidence interval (CI): 2.16-2.47; HRMen = 2.17; 95% CI: 2.05-2.30] and those in the South (HR vs. Northeast: HRWomen = 1.18; 95% CI: 1.07-1.29; HRMen = 1.42; 95% CI: 1.31-1.55) or in rural counties (HR vs. metro: HRWomen = 1.74; 95% CI: 1.47-2.07; HRMen = 1.57; 95% CI: 1.33-1.86). Mortality from CVD and ID was also elevated among non-Hispanic Black AYAs.
CONCLUSIONS: Results of this study suggest that noncancer mortality after AYA cancer is highest among survivors who are non-Hispanic Black or live in the South or in rural counties. IMPACT: Our analyses highlight disparities among AYAs with cancer and identify subgroups that may be targeted for increased medical surveillance or behavioral interventions. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31209147      PMCID: PMC6726505          DOI: 10.1158/1055-9965.EPI-18-1384

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

1.  Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland.

Authors:  Pinki K Prasad; Lisa B Signorello; Debra L Friedman; John D Boice; Eero Pukkala
Journal:  Pediatr Blood Cancer       Date:  2011-09-09       Impact factor: 3.167

2.  Long-term cause-specific mortality among survivors of childhood cancer.

Authors:  Raoul C Reulen; David L Winter; Clare Frobisher; Emma R Lancashire; Charles A Stiller; Meriel E Jenney; Roderick Skinner; Michael C Stevens; Michael M Hawkins
Journal:  JAMA       Date:  2010-07-14       Impact factor: 56.272

3.  Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.

Authors:  Amy C MacArthur; John J Spinelli; Paul C Rogers; Karen J Goddard; Zenaida U Abanto; Mary L McBride
Journal:  Pediatr Blood Cancer       Date:  2007-04       Impact factor: 3.167

4.  Sex mortality differences in the United States: the role of cohort smoking patterns.

Authors:  Samuel H Preston; Haidong Wang
Journal:  Demography       Date:  2006-11

5.  Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades--experience from the Nordic countries.

Authors:  Stanislaw Garwicz; Harald Anderson; Jørgen H Olsen; Jeanette Falck Winther; Risto Sankila; Frøydis Langmark; Laufey Tryggvadóttir; Torgil R Möller
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

6.  Cancer risk in people infected with human immunodeficiency virus in the United States.

Authors:  Eric A Engels; Robert J Biggar; H Irene Hall; Helene Cross; Allison Crutchfield; Jack L Finch; Rebecca Grigg; Tara Hylton; Karen S Pawlish; Timothy S McNeel; James J Goedert
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

7.  Long-term cause-specific mortality among five-year survivors of childhood cancer.

Authors:  M C Cardous-Ubbink; R C Heinen; N E Langeveld; P J M Bakker; P A Voûte; H N Caron; F E van Leeuwen
Journal:  Pediatr Blood Cancer       Date:  2004-06       Impact factor: 3.167

Review 8.  Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

Authors:  Gregory T Armstrong; Qi Liu; Yutaka Yasui; Joseph P Neglia; Wendy Leisenring; Leslie L Robison; Ann C Mertens
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

9.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

10.  Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Authors:  Ann C Mertens; Qi Liu; Joseph P Neglia; Karen Wasilewski; Wendy Leisenring; Gregory T Armstrong; Leslie L Robison; Yutaka Yasui
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 11.816

View more
  8 in total

1.  Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Amy M Berkman; Clark R Andersen; Branko Cuglievan; David C McCall; Philip J Lupo; Susan K Parsons; Courtney D DiNardo; Nicholas J Short; Nitin Jain; Tapan M Kadia; J A Livingston; Michael E Roth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-06-01       Impact factor: 4.090

2.  Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers.

Authors:  Hyuna Sung; Rebecca L Siegel; Noorie Hyun; Kimberly D Miller; K Robin Yabroff; Ahmedin Jemal
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

3.  Long-term survival among 5-year survivors of adolescent and young adult cancer.

Authors:  Amy M Berkman; J A Livingston; Kelly Merriman; Michelle Hildebrandt; Jian Wang; Seyedeh Dibaj; Jennifer McQuade; Nancy You; Anita Ying; Carlos Barcenas; Diane Bodurka; April DePombo; Hun Ju Lee; John de Groot; Michael Roth
Journal:  Cancer       Date:  2020-06-02       Impact factor: 6.860

4.  Disparities in Cancer Survival Among Adolescents and Young Adults: A Population-Based Study of 88 000 Patients.

Authors:  Caitlin C Murphy; Philip J Lupo; Michael E Roth; Naomi J Winick; Sandi L Pruitt
Journal:  J Natl Cancer Inst       Date:  2021-08-02       Impact factor: 13.506

5.  Preventive health service use among survivors of adolescent and young adult cancer.

Authors:  Hilary C Tanenbaum; Lanfang Xu; Erin E Hahn; Julie Wolfson; Smita Bhatia; Kim Cannavale; Robert Cooper; Chun Chao
Journal:  Prev Med Rep       Date:  2020-12-01

Review 6.  Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes.

Authors:  Rachel E Ohman; Eric H Yang; Melissa L Abel
Journal:  J Am Heart Assoc       Date:  2021-12-16       Impact factor: 6.106

7.  Impact of Race, Ethnicity, and Socioeconomic Status over Time on the Long-term Survival of Adolescent and Young Adult Hodgkin Lymphoma Survivors.

Authors:  Amy M Berkman; Clark R Andersen; Vidya Puthenpura; J Andrew Livingston; Sairah Ahmed; Branko Cuglievan; Michelle A T Hildebrandt; Michael E Roth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-08       Impact factor: 4.254

8.  Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors.

Authors:  Alexa C O Medica; Brian W Whitcomb; Ksenya Shliakhsitsava; Andrew C Dietz; Kelsey Pinson; Christina Lam; Sally A D Romero; Patrick Sluss; Mary D Sammel; H Irene Su
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.